An interventional study of Urodynamic investigations before and after a trans-obturator tape protocol. and Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O) in Stress Urinary Incontinence, sponsored by Mackay Medical College. Recruiting at 1 site in Taiwan. Open to female participants aged 30 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-09-05.
Sponsored by Mackay Medical College · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Urinary Incontinence, Stress with a site in Taiwan — 3 open to participants now, 3 under way, none of them phase 3. Urinary Incontinence, Stress · Taiwan.
Among the 18 studies in Urinary Incontinence, Stress with a site in Taiwan, this one is one of 2 that started in 2021, is one of 6 with no phase, and was the 10th registered.
655 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.
Browse Urinary Incontinence, Stress studies →3 of the 18 studies in Urinary Incontinence, Stress with a site in Taiwan are open now. Recruiting first, the newest first:
Taipei Veterans General Hospital, Taiwan · Sites in Taiwan
Ages 18+ · Women only · Healthy volunteers
Far Eastern Memorial Hospital · Sites in Taiwan
Ages 20+ · Women only
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 76 Urinary Incontinence, Stress studies recruiting now, 43 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.
This study: 30 Years to 100 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 2 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 68 across 510 interventional studies indexed under Urinary Incontinence, Stress.
Median enrollment 120 across the 9 interventional studies, 184 across the 9 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 18 have an industry lead sponsor. The 7 most frequent:
Mackay Medical College is the lead sponsor of 20 studies on the registry; 8 are open to participants now.
Mackay Medical College has 1 study filed under Urinary Incontinence, Stress — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Urinary Incontinence, Stress with a site in Taiwan, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The trans-obturator tape (TOT), which exhibits a satisfactory cure rate and a relatively diminished invasiveness, has been increasingly accepted as a surgical treatment of stress urinary incontinence (SUI) patients. Nevertheless, in contrast to the well-recognized therapeutic benefit of the enhanced resistance to the bladder continence during urine storage, if the voiding function of the bladder adapts to the TOT-enhanced outlet resistance has not been adequately investigated. This study retrospectively assayed the voiding efficacy of each voiding cycle, to clarify if the thermodynamic efficacy of the bladder was modified in response to the TOT surgery.
The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min. All patients received a pre- and a post-operative urodynamic evaluation, in which pre-operative evaluation was conducted 1-4 weeks before TOT procedure, and post-operative evaluation was done at 4-6 weeks follow-up.
Complete multichannel urodynamic studies including free uroflowmetry, filling and voiding cystometry, and urethral pressure profile was performed in each patient. The urodynamic parameters measured were the maximum flow rate (Qmax), voided volume, post-void residual volume (PVR), and detrusor pressure at Qmax (Pdet. Qmax). The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline at an infusion rate of 80 ml/min. All data were recorded and analyzed using a Medical Measurement Systems (MMS UD-200, Enschede, The Netherlands). All data in this study will be expressed as mean ± SEM. After checking the normality and variance of data, two-way ANOVAs were used to assess the difference in values among testing groups and time points; and post hoc Student-Newman-Keuls tests were used to compare the means of groups when there was a significant difference between groups. Significance was set at p\<0.05.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Data obtained before the operation
Procedure: Urodynamic investigations before and after a trans-obturator tape protocol.
Data obtained after the operation
Procedure: Urodynamic investigations before and after a trans-obturator tape protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
Data obtained before the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained before the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained after the operation.
Procedure: Urodynamic investigations before and after a mini Arc protocol.
Data obtained before the operation
Procedure: Urodynamic investigations before and after an Solyx sling protocol.
Data obtained before the operation
Procedure: Urodynamic investigations before and after an Solyx sling protocol.
Urodynamic investigations (The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min.)
Urodynamic investigations (stated above.)
Urodynamic investigations (stated above)
Urodynamic investigations (stated above)
Urodynamic investigations (stated above.)
Pressure-volume study
urine leakage.
Time frame: within a voiding cycle (a cycle is about 30 to 60 minutes)
Plan to share: No — For we uncertain if this might violate personal information laws in our country.
Started Mar 2021 (actual). Primary completion is estimated for Mar 2026, 60 months after the start.
Of 227 non-industry interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 60 months is above that.
Counting every sponsor, half of 268 studies reached it within 19 months; a quarter within 9 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Urinary Incontinence, Stress →
Mackay Medical College